TegoScience Inc. (KOSDAQ:191420)
South Korea · Delayed Price · Currency is KRW 12,560
-220 (-1.72%)
At close: Apr 2, 2026
TegoScience Revenue
In the year 2025, TegoScience had annual revenue of 5.94B KRW, down -12.11%. TegoScience had revenue of 1.39B in the quarter ending December 31, 2025, a decrease of -13.31%.
Revenue
5.94B
Revenue Growth
-12.11%
P/S Ratio
16.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
100.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.94B | -818.34M | -12.11% |
| Dec 31, 2024 | 6.76B | -1.01B | -13.04% |
| Dec 31, 2023 | 7.77B | 94.02M | 1.22% |
| Dec 31, 2022 | 7.68B | -621.23M | -7.49% |
| Dec 31, 2021 | 8.30B | -489.49M | -5.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CTCBIO | 123.77B |
| KoBioLabs | 69.29B |
| Cell Biotech | 53.13B |
| Choong Ang Vaccine Laboratory | 39.19B |
| CORESTEMCHEMON | 20.16B |
| BIO-FD&C | 19.18B |
| Quratis | 2.46B |
| NovMetaPharma | 1.30B |